Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your news and products using creative marketing strategies.

Become a Part of Our Family

Our Advertising Marketing Packages Include

    • E-Newsletter Campaigns – Designed to reach the inboxes of professionals and specialists
    • Social Media Campaigns – We will broadcast your ad or information with a variety of tags and headlines, encouraging readers to visit our site to view your entire article.
    • Website Banner Campaigns – From banners and half-page ads to smaller rectangular or square ads, we’ll help you identify the right fit for you and do our best to get you placed on your exact page preference within our website.
    • With a variety of marketing packages for you to choose from – all at cost-effective rates – there is no simpler or more convenient way to reach medical professionals with your company’s latest device or technology.
    • Begin by emailing us directly at advmdn@infomeddnews.com to request additional information. We’ll ask a few preliminary questions that will help us determine if you’re a good fit for our online publication, and then from there, we can help you determine which package is right for your specific article and release. Please also include any specific questions you might have about our process, publication, or company as a whole, and we’ll be happy to discuss them with you.
    • While it can be challenging to capture the attention of the right medical professionals and interest them in learning more about what you have to offer, it’s not impossible. Our trusted team of experts makes it even easier. Reach out to us today to get started.

Readership

Cardiothoracic Surgeons
General Surgeons
Interventional Cardiologists
Interventional Radiologists
Neurosurgeons
Orthopedic Surgeons
OB/GYN Surgeons
Plastic Surgeons
Ophthalmic Surgeons
Urologic Surgeons
Vascular Surgeons

Medical Device Industry Marketing Sales Executives
Venture Capitalists
Other Allied Health Professionals

Get Started Today: If you’re looking for a way to stretch your marketing budget while simultaneously enabling it to have a greater impact and produce higher results, then advertise with Medical Device News Magazine.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”